In additional to the epidemiologic evidence of an excess risk for both bone and STS in hereditary Rb patients, structural alterations of the RB1 gene are well documented in primary bone sarcomas[33] and soft tissue sarcomas[34-36]. This evidence concerns the gene RB1 and soft tissue sarcoma.